Drug Shortage Report for METHOTREXATE SUBCUTANEOUS
Report ID | 211388 |
Drug Identification Number | 02491346 |
Brand name | METHOTREXATE SUBCUTANEOUS |
Common or Proper name | METHOTREXATE SUBCUTANEOUS |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-22 |
Estimated end date | 2024-01-19 |
Actual end date | 2024-01-15 |
Shortage status | Resolved |
Updated date | 2024-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-19 | French | Compare |
v9 | 2024-01-19 | English | Compare |
v8 | 2024-01-05 | French | Compare |
v7 | 2024-01-05 | English | Compare |
v6 | 2023-12-29 | French | Compare |
v5 | 2023-12-29 | English | Compare |
v4 | 2023-12-01 | French | Compare |
v3 | 2023-12-01 | English | Compare |
v2 | 2023-11-24 | French | Compare |
v1 | 2023-11-24 | English | Compare |
Showing 1 to 10 of 10